Breast cancer trial patient participants younger than ever: Phesi
The company’s analysis of 2.5m patients worldwide suggest a growing proportion of younger patients, with implications for future study design and deployment.
Archives for May 16, 2022
Novartis looks to work more strategically as CDMO
Novartis has recently set up a new contract development and manufacturing unit called Global Biotech Co-operations (GBTC).
Trialjectory, foundation to connect blood cancer patients with trials
The cancer trial-matching company is partnering with MPN Research Foundation to help match patients with a group of rare blood cancers to clinical trials.
Helping Sponsors Navigate Complex Ancillary Supply Sourcing Challenges with Integrated Services
Paid for and content provided by Yourway
As the clinical trial landscape becomes increasingly complex, the needs of trials sponsors with respect to ancillary clinical suppliers also become more intricate. Many more types of supplies, including medical equipment and diagnostic tests, are needed...